StemSmart™ MSC – Diabetic Nephropathy
Kidney Inflammatory Disease
PreclinicalPlanned
Key Facts
Indication
Kidney Inflammatory Disease
Phase
Preclinical
Status
Planned
About Neuroscientific Biopharmaceuticals
Australian MSC biotech advancing StemSmart™ therapy for Crohn’s disease and other inflammatory disorders.
View full company profile